Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Denison Mines stock logo

1. Denison Mines NYSEAMERICAN:DNN

$1.81 +0.02 (+1.12%)
Closing price 02/7/2025 04:10 PM Eastern
Extended Trading
$1.82 +0.01 (+0.55%)
As of 08:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.60 billion
Consensus Rating
Strong Buy
Consensus Price Target
$3.00 (+65.7% Upside)
Volume
49.90 million shares
Average Volume
35.77 million shares
Today's Range
$1.79
$1.86
Mereo BioPharma Group stock logo

2. Mereo BioPharma Group NASDAQ:MREO

$3.11 +0.01 (+0.32%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$3.09 -0.02 (-0.51%)
As of 08:47 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$480.95 million
Consensus Rating
Buy
Consensus Price Target
$7.83 (+151.9% Upside)
Volume
916,381 shares
Average Volume
1.22 million shares
Today's Range
$3.03
$3.12
Quince Therapeutics stock logo

3. Quince Therapeutics NASDAQ:QNCX

$1.48 -0.10 (-6.33%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$1.52 +0.04 (+3.04%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$69.52 million
Consensus Rating
Buy
Consensus Price Target
$9.50 (+541.9% Upside)
Volume
347,655 shares
Average Volume
126,175 shares
Today's Range
$1.43
$1.60
enCore Energy stock logo

4. enCore Energy NASDAQ:EU

$2.92 -0.06 (-2.01%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$2.96 +0.04 (+1.37%)
As of 08:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore Energy

Market Capitalization
$554.62 million
Consensus Rating
Buy
Consensus Price Target
$6.50 (+122.6% Upside)
Volume
1.43 million shares
Average Volume
1.54 million shares
Today's Range
$2.91
$3.01
Achieve Life Sciences stock logo

5. Achieve Life Sciences NASDAQ:ACHV

$3.05 -0.16 (-4.98%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$3.24 +0.19 (+6.23%)
As of 08:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life Sciences

Market Capitalization
$110.39 million
Consensus Rating
Buy
Consensus Price Target
$14.80 (+385.2% Upside)
Volume
149,912 shares
Average Volume
255,653 shares
Today's Range
$3.02
$3.23
Solid Biosciences stock logo

6. Solid Biosciences NASDAQ:SLDB

$2.88 -0.25 (-7.99%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$3.46 +0.58 (+19.97%)
As of 09:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid Biosciences

Market Capitalization
$125.06 million
Consensus Rating
Buy
Consensus Price Target
$15.30 (+431.3% Upside)
Volume
766,674 shares
Average Volume
499,346 shares
Today's Range
$2.88
$3.20
Aclaris Therapeutics stock logo

7. Aclaris Therapeutics NASDAQ:ACRS

$2.49 +0.06 (+2.47%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$2.57 +0.08 (+3.21%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$177.86 million
P/E Ratio
-4.79
Consensus Rating
Buy
Consensus Price Target
$11.00 (+341.8% Upside)
Volume
715,171 shares
Average Volume
914,994 shares
Reviva Pharmaceuticals stock logo

8. Reviva Pharmaceuticals NASDAQ:RVPH

$2.08 +0.01 (+0.48%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$2.04 -0.04 (-1.68%)
As of 08:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$69.22 million
Consensus Rating
Buy
Consensus Price Target
$11.40 (+448.1% Upside)
Volume
1.38 million shares
Average Volume
1.77 million shares
Today's Range
$1.97
$2.12
Nkarta stock logo

9. Nkarta NASDAQ:NKTX

$2.17 -0.17 (-7.26%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$2.21 +0.04 (+1.84%)
As of 08:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization
$165.13 million
P/E Ratio
-1.15
Consensus Rating
Buy
Consensus Price Target
$15.00 (+591.2% Upside)
Volume
633,631 shares
Average Volume
1.03 million shares
GeoVax Labs stock logo

10. GeoVax Labs NASDAQ:GOVX

$1.70 -0.01 (-0.58%)
As of 02/7/2025 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$16.14 million
Consensus Rating
Buy
Consensus Price Target
$14.20 (+735.3% Upside)
Volume
386,120 shares
Average Volume
584,823 shares
Today's Range
$1.67
$1.76
Rezolve AI stock logo

11. Rezolve AI NASDAQ:RZLV

$3.14 +0.17 (+5.72%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$3.24 +0.11 (+3.34%)
As of 09:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$540.66 million
Consensus Rating
Buy
Consensus Price Target
$6.40 (+103.8% Upside)
Volume
12.01 million shares
Average Volume
7.42 million shares
Today's Range
$2.85
$3.22
Cardiol Therapeutics stock logo

12. Cardiol Therapeutics NASDAQ:CRDL

$1.35 -0.10 (-6.90%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$1.42 +0.06 (+4.81%)
As of 08:49 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$119.78 million
Consensus Rating
Buy
Consensus Price Target
$8.40 (+522.2% Upside)
Volume
295,052 shares
Average Volume
244,533 shares
Today's Range
$1.31
$1.49
Immunic stock logo

13. Immunic NASDAQ:IMUX

$0.96 -0.02 (-1.98%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$0.98 +0.02 (+2.53%)
As of 08:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$88.29 million
P/E Ratio
-0.78
Consensus Rating
Buy
Consensus Price Target
$12.67 (+1,218.5% Upside)
Volume
424,888 shares
Average Volume
992,769 shares
Amprius Technologies stock logo

14. Amprius Technologies NYSE:AMPX

$3.60 +0.19 (+5.43%)
Closing price 02/7/2025 03:59 PM Eastern
Extended Trading
$3.71 +0.12 (+3.20%)
As of 08:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amprius Technologies, Inc produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. More about Amprius Technologies

Market Capitalization
$360.91 million
Consensus Rating
Buy
Consensus Price Target
$9.29 (+158.3% Upside)
Volume
3.79 million shares
Average Volume
3.56 million shares
Today's Range
$3.43
$3.74
HIVE Digital Technologies stock logo

15. HIVE Digital Technologies NASDAQ:HIVE

$2.83 -0.02 (-0.70%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$2.89 +0.06 (+2.12%)
As of 08:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital Technologies

Market Capitalization
$422.01 million
Consensus Rating
Buy
Consensus Price Target
$7.58 (+168.0% Upside)
Volume
14.65 million shares
Average Volume
10.18 million shares
Today's Range
$2.81
$3.08
Unicycive Therapeutics stock logo

16. Unicycive Therapeutics NASDAQ:UNCY

$0.57 -0.04 (-7.13%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$0.57 +0.00 (+0.78%)
As of 08:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Unicycive Therapeutics, Inc, a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. More about Unicycive Therapeutics

Market Capitalization
$63.21 million
Consensus Rating
Buy
Consensus Price Target
$5.50 (+872.4% Upside)
Volume
691,045 shares
Average Volume
955,472 shares
Today's Range
$0.56
$0.61
Invivyd stock logo

17. Invivyd NASDAQ:IVVD

$2.04 +0.06 (+3.03%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$2.07 +0.03 (+1.42%)
As of 08:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. More about Invivyd

Market Capitalization
$244.03 million
P/E Ratio
-1.04
Consensus Rating
Buy
Consensus Price Target
$7.89 (+286.6% Upside)
Volume
27.29 million shares
Average Volume
36.38 million shares
Lucid Diagnostics stock logo

18. Lucid Diagnostics NASDAQ:LUCD

$1.07 +0.10 (+10.56%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$1.09 +0.02 (+1.87%)
As of 08:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid Diagnostics

Market Capitalization
$57.43 million
Consensus Rating
Buy
Consensus Price Target
$3.63 (+238.8% Upside)
Volume
781,608 shares
Average Volume
194,222 shares
Today's Range
$0.95
$1.07
Clene stock logo

19. Clene NASDAQ:CLNN

$4.36 -0.06 (-1.36%)
Closing price 02/7/2025 03:59 PM Eastern
Extended Trading
$4.37 +0.01 (+0.25%)
As of 08:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Clene Inc, a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. More about Clene

Market Capitalization
$36.80 million
Consensus Rating
Buy
Consensus Price Target
$55.25 (+1,167.2% Upside)
Volume
54,823 shares
Average Volume
47,025 shares
Today's Range
$4.15
$4.43
KORU Medical Systems stock logo

20. KORU Medical Systems NASDAQ:KRMD

$4.62 -0.23 (-4.74%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$4.62 +0.00 (+0.09%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. More about KORU Medical Systems

Market Capitalization
$222.31 million
P/E Ratio
-18.48
Consensus Rating
Buy
Consensus Price Target
$4.50 (-2.6% Downside)
Volume
236,592 shares
Average Volume
259,462 shares
FibroBiologics stock logo

21. FibroBiologics NASDAQ:FBLG

$1.86 +0.26 (+16.25%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$1.89 +0.03 (+1.40%)
As of 08:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$58.25 million
Consensus Rating
Buy
Consensus Price Target
$13.00 (+598.9% Upside)
Volume
2.27 million shares
Average Volume
208,281 shares
Today's Range
$1.75
$2.00
Gain Therapeutics stock logo

22. Gain Therapeutics NASDAQ:GANX

$2.61 -0.03 (-1.14%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$2.52 -0.09 (-3.26%)
As of 08:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain Therapeutics

Market Capitalization
$70.03 million
Consensus Rating
Buy
Consensus Price Target
$7.25 (+177.8% Upside)
Volume
357,438 shares
Average Volume
178,451 shares
Today's Range
$2.43
$2.75
Western Copper & Gold stock logo

23. Western Copper & Gold NYSE:WRN

$1.09 0.00 (0.00%)
As of 02/7/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$216.25 million
Consensus Rating
Buy
Consensus Price Target
$4.25 (+289.9% Upside)
Volume
239,070 shares
Average Volume
261,528 shares
Today's Range
$1.07
$1.13
Journey Medical stock logo

24. Journey Medical NASDAQ:DERM

$4.99 -0.01 (-0.20%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$4.84 -0.15 (-3.03%)
As of 08:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. More about Journey Medical

Market Capitalization
$104.45 million
Consensus Rating
Buy
Consensus Price Target
$9.38 (+87.9% Upside)
Volume
68,992 shares
Average Volume
56,228 shares
Today's Range
$4.67
$5.15
Genelux stock logo

25. Genelux NASDAQ:GNLX

$4.28 -0.15 (-3.39%)
Closing price 02/7/2025 04:00 PM Eastern
Extended Trading
$4.38 +0.10 (+2.34%)
As of 08:56 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. More about Genelux

Market Capitalization
$153 million
Consensus Rating
Buy
Consensus Price Target
$18.25 (+326.4% Upside)
Volume
220,676 shares
Average Volume
303,990 shares
Today's Range
$4.10
$4.67